Clinical Trial Update: Efficacy and Safety/Tolerability of Grass MATA MPL [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety/tolerability of Grass MATA MPL for Type I hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• Grass MATA MPL (grass pollen extract with MPL adjuvant)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 3 | Status: COMPLETED